Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson–Gilford Progeria Syndrome
Beatriz Marcos‐Ramiro, Ana Gil-Ordóñez, Nagore I. Marín‐Ramos, et al.
ACS Central Science (2021) Vol. 7, Iss. 8, pp. 1300-1310
Open Access | Times Cited: 25

Showing 25 citing articles:

The structure and function of lamin A/C: Special focus on cardiomyopathy and therapeutic interventions
Vikas Tiwari, Md Jahangir Alam, M L Bhatia, et al.
Life Sciences (2024) Vol. 341, pp. 122489-122489
Closed Access | Times Cited: 8
The Molecular and Cellular Basis of Hutchinson–Gilford Progeria Syndrome and Potential Treatments
Noelle J. Batista, Sanket G. Desai, Alexis M. Perez, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 602-602
Open Access | Times Cited: 15
Upstream Proteolysis by Ste24 does not Require a C-Terminal Methyl Ester as Revealed Using 33-Residue a-Factor Precursor Peptide Substrates Synthesized via Epimerization-Free Methods
Taysir K. Bader, Stuart B. Brown, Christine A. Hrycyna, et al.
International Journal of Peptide Research and Therapeutics (2025) Vol. 31, Iss. 2
Open Access
Small-Molecule Therapeutic Perspectives for the Treatment of Progeria
Jon Macicior, Beatriz Marcos‐Ramiro, Silvia Ortega‐Gutiérrez
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7190-7190
Open Access | Times Cited: 20
Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome
Sae‐Il Murtada, Nicole Mikush, Mo Wang, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 7
Senescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissues
Loïc Rolas, Monja Stein, Anna Barkaway, et al.
EMBO Reports (2024) Vol. 25, Iss. 9, pp. 3842-3869
Open Access | Times Cited: 2
Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson–Gilford Progeria Syndrome
So‐mi Kang, Seungwoon Seo, Eun Ju Song, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1232-1232
Open Access | Times Cited: 6
New Trends in Aging Drug Discovery
Bellinda Benhamú, Mar Martı́n-Fontecha, Henar Vázquez‐Villa, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2006-2006
Open Access | Times Cited: 9
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice
Nora Khiar‐Fernández, Debora Zian, Henar Vázquez‐Villa, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 10956-10974
Open Access | Times Cited: 8
Roles of the lamin A-specific tail region in the localization to sites of nuclear envelope rupture
Yohei Kono, Chan‐Gi Pack, Takehiko Ichikawa, et al.
PNAS Nexus (2024) Vol. 3, Iss. 12
Open Access | Times Cited: 1
Progeria: a perspective on potential drug targets and treatment strategies
Ignacio Benedicto, Xue Chen, Martin O. Bergö, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 393-399
Open Access | Times Cited: 6
Status of treatment strategies for Hutchinson–Gilford progeria syndrome with a focus on prelamin: A posttranslational modification
Xue Chen, Haidong Yao, Vicente Andrés, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 131, Iss. 4, pp. 217-223
Open Access | Times Cited: 6
A new fluorescent probe for the visualization of progerin
Jon Macicior, D.M. Fernandez, Silvia Ortega‐Gutiérrez
Bioorganic Chemistry (2023) Vol. 142, pp. 106967-106967
Open Access | Times Cited: 3
Progerin-Induced Impairment in Wound Healing and Proliferation in Vascular Endothelial Cells
Yizhi Jiang, Julie Y. Ji
Frontiers in Aging (2022) Vol. 3
Open Access | Times Cited: 5
Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry
Emilio Camafeita, Inmaculada Jorge, José Rivera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11733-11733
Open Access | Times Cited: 3
Nuclear envelope budding inhibition slows down progerin-induced aging process
Xiangyang Wang, Lin Ma, Di Lu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access
Hutchinson–Gilford progeria syndrome: unraveling the genetic basis, symptoms, and advancements in therapeutic approaches
Akhil Arun, Athira Rejith Nath, Bonny Thankachan, et al.
Therapeutic Advances in Rare Disease (2024) Vol. 5
Open Access
Targeting RAS membrane association
Mei Wang, Patrick J. Casey, Cristina Nuevo Tapioles, et al.
Elsevier eBooks (2024), pp. 37-60
Closed Access
Chemical probes for the identification of the molecular targets of honokiol
Henar Vázquez‐Villa, Ainoa Rueda‐Zubiaurre, D.M. Fernandez, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117102-117102
Open Access
Comprehensive analysis of A-type lamin tail region for repairing the nuclear lamina
Yohei Kono, Chan‐Gi Pack, Takehiko Ichikawa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Clinical manifestations and gene analysis of Hutchinson-Gilford progeria syndrome: A case report
Suli Zhang, Shuang-Zhu Lin, Yanqiu Zhou, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 15, pp. 5018-5024
Open Access | Times Cited: 2
New Pharmacological Approaches for Rare Diseases
Silvia Ortega‐Gutiérrez
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7275-7275
Open Access
Terapia génica mediante el Crispr/Cass en el síndrome de Hutchinson Gilford
Kerly Lizbeth Sanchez Eras, Cristian Carlos Ramírez Portilla
(2023)
Open Access
[Research advances in pharmacotherapy for rare diseases in children].
Jiaqi Li, Huijun Wang
PubMed (2023) Vol. 25, Iss. 7, pp. 759-766
Closed Access
Toward a New Therapy for Rapidly Aging Children
Mohamed X. Ibrahim, Martin O. Bergö
ACS Central Science (2021) Vol. 7, Iss. 8, pp. 1292-1294
Open Access
Page 1

Scroll to top